North South Ventures

Noetik is an AI-native biotechnology company focused on the discovery and development of cancer immunotherapies. Utilizing advanced machine learning techniques, Noetik's platform identifies new therapeutic targets and designs innovative treatments. By harnessing self-supervised learning and integrating diverse human multimodal data, the company aims to enhance the precision and effectiveness of immunotherapies. This approach enables the development of more personalized cancer treatments, contributing to the advancement of targeted therapies in oncology.

LunaJoy specializes in virtual mental health services tailored for women. It offers online counseling, therapy, psychiatry, and coaching by licensed professionals, accessible via phone or video calls. The platform provides personalized care plans and 24/7 support.

Tiny Health is a prominent microbiome health platform focused on addressing chronic health conditions and optimizing overall well-being. The company offers innovative at-home microbiome testing kits, including the Gut Health Test specifically designed for pregnant mothers and their babies, as well as tests for older children and adults and Vaginal Health Tests. By utilizing shotgun metagenomics, Tiny Health provides families with personalized insights into their gut and vaginal microbiomes, allowing them to make informed dietary and lifestyle changes. To date, approximately 30,000 families have relied on Tiny Health's expertise to correct microbiome imbalances and enhance health outcomes, with many experiencing significant symptom reduction or even reversal of chronic conditions. The team at Tiny Health comprises leading scientists and medical professionals from prestigious institutions, ensuring a strong foundation in evidence-based health solutions.

Cocoon Bioscience helps catalyze the expansion of bottlenecked industries like cultivated meat by manufacturing performance and growth factors and specialized enzymes for individual protein, nutrition, and healthcare applications.

Noetik is an AI-native biotechnology company focused on the discovery and development of cancer immunotherapies. Utilizing advanced machine learning techniques, Noetik's platform identifies new therapeutic targets and designs innovative treatments. By harnessing self-supervised learning and integrating diverse human multimodal data, the company aims to enhance the precision and effectiveness of immunotherapies. This approach enables the development of more personalized cancer treatments, contributing to the advancement of targeted therapies in oncology.

Founded in 2014, QuantumCyte develops an automated tissue dissection system that uses digital maps to isolate regions of interest containing informative biomarkers. This platform aims to improve cancer outcomes by enabling precise cellular data analysis for predicting drug efficacy.

Basys.ai streamlines healthcare administration by automating prior authorization and utilization management processes for health plans using an AI-based platform. This proprietary system digitizes payer policies via machine learning, reducing implementation timelines significantly.

Miracle is a healthcare technology company that focuses on enhancing clinical operations through its innovative platform. The company integrates various clinical trial platforms and vendor data into a unified dashboard, streamlining the management of patient recruitment processes. By automating the compilation of reports, Miracle's solution significantly reduces the time spent on data management and provides real-time insights. This enables clinics and hospitals to access critical information swiftly, thereby optimizing return on investment and accelerating patient recruitment efforts.

Droplet Biosciences enhances cancer diagnosis through its innovative lymphatic fluid analysis technology. This non-invasive liquid biopsy method enables healthcare professionals to make more informed post-operative treatment decisions.

Cocoon Bioscience helps catalyze the expansion of bottlenecked industries like cultivated meat by manufacturing performance and growth factors and specialized enzymes for individual protein, nutrition, and healthcare applications.

LunaJoy specializes in virtual mental health services tailored for women. It offers online counseling, therapy, psychiatry, and coaching by licensed professionals, accessible via phone or video calls. The platform provides personalized care plans and 24/7 support.

Tiny Health is a prominent microbiome health platform focused on addressing chronic health conditions and optimizing overall well-being. The company offers innovative at-home microbiome testing kits, including the Gut Health Test specifically designed for pregnant mothers and their babies, as well as tests for older children and adults and Vaginal Health Tests. By utilizing shotgun metagenomics, Tiny Health provides families with personalized insights into their gut and vaginal microbiomes, allowing them to make informed dietary and lifestyle changes. To date, approximately 30,000 families have relied on Tiny Health's expertise to correct microbiome imbalances and enhance health outcomes, with many experiencing significant symptom reduction or even reversal of chronic conditions. The team at Tiny Health comprises leading scientists and medical professionals from prestigious institutions, ensuring a strong foundation in evidence-based health solutions.

Orchid is a reproductive technology startup founded in 2019 and headquartered in San Francisco, California. The company specializes in detecting rare genetic disorders through its preconception system, which analyzes the genomes of both partners to assess their genetic predispositions to various common diseases, such as heart disease, Alzheimer’s disease, and breast cancer. Orchid develops its results in collaboration with leading experts in reproductive medicine and genetics, ensuring high accuracy. The company offers a "Couple Report," which utilizes an at-home saliva test to evaluate each individual’s genetic profile and predict potential genetic risks for future children. In cases of elevated risk, Orchid provides actionable insights to assist couples in monitoring health markers, adjusting their diet, or considering procedures like in vitro fertilization.

Slingshot Bills analyzes medical claims for errors and overcharges with the goal of removing them. The platform helps companies save $600 per employee annually. And connects to client claims data through TPAs.

YourChoice Therapeutics, Inc. is a biotechnology company based in Berkeley, California, founded in 2018. The company focuses on developing non-hormonal contraceptive products aimed at providing women with safe and effective birth control options. Its innovative technology is based on the concept of a "molecular condom," which utilizes an active compound to inhibit sperm motility, thereby preventing sperm from fertilizing the egg. This approach seeks to eliminate the risks and side effects commonly associated with traditional hormonal contraceptive methods, offering a promising alternative for those seeking safer birth control solutions.

Persephone Biome, Inc. is a San Diego-based company focused on researching and developing products and therapies that modify gut microbial metabolism, particularly in relation to cancer treatment. Established in 2017, the company is creating innovative solutions aimed at enhancing the efficacy of oncology drugs by retuning the gut microbiome. This includes the development of a pill containing beneficial gut bacteria. In addition to its therapeutics, Persephone Biome aims to offer nutritional products that support the human gut microbiome, producing functional foods and beverages that cater to the growing consumer demand for health-oriented products. The company has plans to enter clinical trials to further advance its initiatives in the field of microbiome-directed therapies.

Solving cancer resistance.

Talus Bio is a biotechnology startup focused on drug discovery and development, particularly targeting challenging cancer transcription factors. The company employs an innovative approach that integrates functional proteomics, automated biology, and machine learning. Their MARMOT platform utilizes AI, advanced proteomics, synthetic chemistry, and computational biology to design and analyze drugs, proteins, and genomics. This platform is designed to advance drug development for gene regulation in oncology, aiming to create small-molecule therapies that can effectively control gene expression in cancer cells.

Syrona Health is a digital health company focused on personalized gynecological care throughout various life stages, including menstrual health, fertility, parenthood, and menopause. It offers a virtual health support platform that integrates software and hardware to enhance gynecological health outcomes. The company's solutions address conditions such as endometriosis, polycystic ovary syndrome (PCOS), and gynecological cancers, enabling women to monitor their health independently. Syrona Health also provides at-home clinical testing and online counseling, allowing women to manage their gynecological health proactively without relying on lengthy clinic visits for diagnostics.

Samos Insurance is a provider of specialized insurance solutions focused on elective surgery. The company operates a platform that offers a unique surgery insurance policy, designed to deliver a death benefit to the insured's family and estate in the event of a fatality during planned surgical procedures. This includes coverage for surgeries such as cesarean sections, joint replacements, heart surgeries, and common cancer diagnostic operations. Samos Insurance aims to make insurance accessible and affordable, offering customers peace of mind during their surgical journeys by protecting them against the risks associated with elective procedures.

Toolchest is a developer of computational biology tools specifically aimed at enhancing drug discovery processes for pharmaceutical companies. The company offers Python and R libraries that enable clients to utilize popular open-source tools efficiently at scale in a cloud environment. By providing pre-implemented application programming interfaces and scalable computing technology, Toolchest allows drug companies to accelerate their data analysis, thereby improving their research and development capabilities.

Zeit Medical is a company focused on advancing the treatment of neurological injuries through innovative technology. Founded in 2019 by Urs Naber and Orestis Vardoulis, the company has developed a specialized headband that continuously monitors the electrical activity of the brain. This device integrates smoothly with existing electroencephalogram (EEG) systems and automates the pre-screening process, facilitating the annotation of extensive datasets. By identifying signature patterns in EEG readings, Zeit Medical enables physicians to diagnose and treat neurological conditions with greater precision, particularly in detecting the onset of strokes.

Kiwi biosciences is a biotech company that develops enzymes to make food for patients who suffer from Irritable Bowel Syndrome (IBS). The company was founded in 2020 and is based in Somerville, Massachusetts, United States.

Commons Clinic is a multispecialty healthcare provider based in Austin, Texas, founded in 2021. It delivers comprehensive specialty and surgical care for pain, orthopedics, women's health, and men's health. The company also develops a healthcare platform that combines preventive diagnostics with specialist-driven interventions, uniting advanced diagnostics, personalized care pathways, and interventional procedures within an accountable system across musculoskeletal care, women's health, and preventive oncology to support informed clinical decisions and improved patient outcomes.

SFA Therapeutics, Inc. is a development-stage biopharmaceutical company based in Jenkintown, Pennsylvania, that specializes in the development of microbiome-derived metabolites as therapeutic agents for chronic inflammatory diseases and cancer. The company focuses on harnessing compounds discovered in the human microbiome to create innovative treatments aimed at addressing conditions such as cancer, liver diseases, and autoimmune disorders. Through its novel platform, SFA Therapeutics seeks to advance the understanding and application of microbiome science in the field of medicine, providing new options for medical professionals in the treatment of these challenging health issues.

Auricle is a medical device startup that is developing a revolutionary neurostimulation implant to restore hearing in millions of people who are no longer helped by hearing aids and are not serviced by existing treatments. The company was founded in 2020 and is based in Mountain View, CA.

SFA Therapeutics, Inc. is a development-stage biopharmaceutical company based in Jenkintown, Pennsylvania, that specializes in the development of microbiome-derived metabolites as therapeutic agents for chronic inflammatory diseases and cancer. The company focuses on harnessing compounds discovered in the human microbiome to create innovative treatments aimed at addressing conditions such as cancer, liver diseases, and autoimmune disorders. Through its novel platform, SFA Therapeutics seeks to advance the understanding and application of microbiome science in the field of medicine, providing new options for medical professionals in the treatment of these challenging health issues.